Assessment of hypertrophic cardiomyopathy using human induced pluripotent stem cell-derived cardiomyocytes reveals abnormal excitation contraction coupling
Publication date: September–October 2019Source: Journal of Pharmacological and Toxicological Methods, Volume 99Author(s): Natsuyo Aoyama, Jing Liu, Souameng Lor, T.K. Feaster, Simon Hilcove, Eugenia Jones
Source: Journal of Pharmacological and Toxicological Methods - Category: Drugs & Pharmacology Source Type: research
More News: Cardiology | Cardiomyopathy | Drugs & Pharmacology | Heart | Hypertrophic Cardiomyopathy | Stem Cell Therapy | Stem Cells | Toxicology